Antipsychotic drug-induced sexual dysfunction is an important and problematic side effect. We have investigated the effect of chronic antipsychotic treatment on sexual behaviour, sex hormones and genital organ size in the male rat. The following sexual functions were significantly impaired in both risperidone (2 mg/kg) and haloperidol (2 mg/kg) groups at 3 weeks: Libido (assessed in mounting frequency and intromission), sexual arousability/motivation (in terms of Latencies for mounting and intromission) and orgasm (in terms of Latency for ejaculation). At 6 weeks, haLoperidol also suppressed the `hit ratio' (intromissions/mounts) as well as the above-mentioned parameters indicating erectile dysfunction. Risperidone had no significant effect on sexual function at 6 weeks. Compared with the control group, haLoperidol and risperidone decreased the serum Level of testosterone after 6 weeks but not after 3 weeks. The two drugs did not influence the serum Level of Leutenizing hormone (LH). At 3 weeks, the epididymis was significantly decreased beLow controls in both risperidone and haloperidol groups. At 6 weeks, the epididymis, seminal vesicle and prostate weights were significantLy reduced in the haLoperidol group, but not in the risperidone group. The serum concentration of testosterone significantly correLated with sex organ weight, but not with sexual behaviours. These results suggest that sexual function, testosterone Levels and genital tissue size in male rats were affected to different degrees by risperidone and haloperidol. These findings contribute to our understanding of antispsychotic drug-induced male sexual dysfunction.
Argiolas A. , Melis M.R. (2003) The neurophysiology of the sexual cycle . J Endocrinol Invest26(S3): 20—22
3.
Baldwin D. , Mayers A. (2003) Sexual side-effects of antidepressant and antipsychotic drugs . Advances in Psychiatric Treatment9: 202—210
4.
Baptista T. , Alastre T. , Contreras Q. , Martinez J.L. , Araujo de Baptista E. , Paez X. , Hernandez L. (1997) Effects of the antipsychotic drug sulpiride on reproductive hormones in healthy men: relationship with body weight regulation . Pharmacopsychiatry30: 250—255
5.
Barnes T R E , Harvey C.A. , (1993) Psychiatric drugs and sexuality. In Riley A J , Peet M , Wilson C (eds), Sexual Pharmacology. Oxford Medical Publications, Oxford :176—196.
6.
Bobes J. , Garca-Portilla M.P. , Rejas J. , Hern Ndez G. , Garcia-Garcia M. , Rico-Villademoros F. , Porras A. (2003) Frequency of sexual dysfunction and other reproductive side-effects in patients with schizophrenia treated with risperidone, olanzapine, quetiapine, or haloperidol: the results of the EIRE study . J Sex Marital Ther29: 125—147
7.
Brown A.S. , Hembree W.C. , Friedman J.H. , Kaufmann C.A. , Gorman J.M. (1995) The gonadal axis in men with schizophrenia . Psychiatry Res57: 231—239
8.
Compton M.T. , Miller A.H. ( 2002) Antipsychotic-induced hyperprolactinemia and sexual dysfunction . Psychopharmacol Bull36: 143—164
9.
Coppenolle V.F. , Slomianny C. , Carpentier F. , Le Bourhis X , Ahidouch A. , Croix D. , Legrand G. , Dewailly E. , Fournier S. , Cousse H. , Authie D. , Raynaud J.P. , Beauvillain J.C. , Dupouy J.P. , Prevarskaya N. (2001) Effects of hyperprolactinemia on rat prostate growth: evidence of androgeno-dependence . Am J Physiol Endocrinol Metab280: E120—129
10.
Cutler A.J. (2003) Sexual dysfunction and antipsychotic treatment . Psychoneuroendocrinology28(suppl.)1: 69—82
11.
Dohle G.R. , Smit M. , Weber R.F. (2003) Androgens and male fertility . World J Urol21: 341—345
12.
Dossenbach M. , Erol A. , el Mahfoud Kessaci M. , Shaheen M.O. , Sunbol M.M. , Boland J. , Hodge A. , O'Halloran R.A. , Bitter I. , IC-SOHO Study Group (2004) Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol . J Clin Psychiatry65: 312—321
13.
Du J. , Hull E.M. (1999) Effects of testosterone on neuronal nitric oxide synthase and tyrosine hydroxylase . Brain Res836: 90—98
14.
Dunbar F. , Kusumakar V. , Daneman D. , Schulz M. (2004) Growth and sexual maturation during long-term treatment with risperidone . Am J Psychiatry161: 918—920
15.
Finn S.E. , Baily J.M. , Schultz R.T. , Faber R. (1990) Subjective utility ratings of neuroleptics in treating schizophrenia . Psychol Med35: 843—848
16.
Giuliano F. , Rampin O. (2000) Central neural regulation of penile erection . Neurosci Biobehav Rev24: 517—533
17.
Halbreich U. , Kahn L.S. (2003) Hormonal aspects of schizophrenias: an overview . Psychoneuroendocrinology28(suppl. 2): 1—16
18.
Heaton J.P. , Adams M.A. (2003) Update on central function relevant to sex: remodeling the basis of drug treatments for sex and the brain . Int J Impot Res. 15(suppl. 5): S25—32
19.
Hull E.M. , Muschamp J.W. , Sato S. ( 2004) Dopamine and serotonin: influences on male sexual behavior . Physiology and Behavior83: 291—307
20.
Hummer M. , Kemmler G. , Kurz M. , Kurzhaler I. , Oberbauer H. , Fleischhacker W.W. (1999) Sexual disturbances during clozapine and haloperidol treatment for schizophrenia . Am J Psychiat4: 631—633
21.
Kaneda Y. (2001) Risperidone-induced ejaculatory dysfunction: a case report . Eur Psychiatry16: 134—135
22.
Kaneda Y. , Fujii A. (2000) Effects of chronic neuroleptic administration on the hypothalamo—pituitary—gonadal axis of male schizophrenics . Prog Neuropsychopharmacol Biol Psychiatry24: 251—258
23.
Kaneda Y. , Fujii A. , Ohmori T. (2002) The hypothalamic—pituitary—adrenal axis in chronic schizophrenic patients long-term treated with euroleptics . Prog Neuropsychopharmacol Biol Psychiatry26: 935—938
24.
Knegtering H. , Lamberts P.A. , Prakken G. , Ten Brink C (2000) Serum prolactin levels and sexual dysfunction in antipsychotic medication, such as risperidone: a review . Acta Neuropsychiatr12: 19—26
25.
Knegtering H. , van der Moolen A.E. , Castelein S. , Kluiter H. , van den Bosch R.J. (2003) What are the effects of antipsychotics on sexual dysfunctions and endocrine functioning?Psychoneuroendocrinology28(suppl. 2): 109—123
26.
Knegtering R. , Castelein S. , Bous H. , Van Der Linde J. , Bruggeman R. , Kluiter H. , van den Bosch R.J. (2004) A randomized open-label study of the impact of quetiapine versus risperidone on sexual functioning . J Clin Psychopharmacol24: 56—61
27.
Kristensen E. (2002) Sexual side effects of treatment with psychopharmaceuticals . Ugeskr Laeger164: 4753—4756
28.
Macdonald S. , Halliday J. , Macewan T. , Sharkey V. , Farrington S. , Wall S. , Mccreadie R.G. (2003) Nithsdale Schizophrenia Surveys 24: sexual dysfunction case — control study . British Journal of Psychiatry182: 50—56
29.
Markianos M. , Hatzimanolis J. , Lykouras L. (1999) Gonadal axis hormones in male schizophrenic patients during treatment with haloperidol and after switch to risperidone . Psychopharmacology (Berl) 143: 270—272
30.
Meston C.M. , Frohlich P.F. (2000) The neurobiology of sexual function . Arch Gen Psychiatry57: 1012—1030
31.
Okonmah A.D. , Bradshaw W.G. , Couceyro P. , Soliman K.F. (1986) The effect of neuroleptic drugs on serum testosterone level in the male rat . Gen Pharmacol17: 235—238
32.
Perkins D.O. (2002) Predictors of noncompliance in patients with schizophrenia . J Clin Psychiatry63: 1121—8 .
33.
Pfaus J.G. , Phillips A.G. (1991) Role of dopamine in anticipatory and consummatory aspects of sexual behavior in the male rat . Behav Neurosci105: 727—743
34.
Ratnasooriya W.D. , Ratnayake S.S. , Jayatunga Y.N. (2002) Effects of pyrethroid insecticide ICON on reproductive competence of male rats . Asian J Androl4: 35—41
35.
Rinieris P. , Hatzimanolis J. , Markianos M. , Stefanis C. (1988) Effects of 4 weeks treatment with chlorpromazine and/or trihexyphenidyl on the pituitary—gonadal axis in male paranoid schizophrenics. Eur Arch PsychiatryNeurol Sci237(4): 189—193
36.
Rinieris P. , Hatzimanolis J. , Markianos M. , Stefanis C. (1989) Effects of treatment with various doses of haloperidol on the pituitary—gonadal axis in male schizophrenic patients . Neuropsychobiology22: 146—149
37.
Roman M.D. , Carulla S.L. , Eroles F.F. (1994) Sexuality and schizophrenia . Acta Psiquiatr Psicol Am Lat40: 195—206
38.
Rosenberg K.P. , Bleiberg K.L. , Koscis J. , Gross C. (2003) A survey of sexual side effects among severely mentally ill patients taking psychotropic medications: impact on compliance . J Sex Marital Ther29(4): 289—296
39.
Smith S. (2003) Effects of antipsychotics on sexual and endocrine function in women: implications for clinical practice . J Clin Psychopharmacol23(3 suppl. 1): S27—32
40.
Smith S. , Wheeler M.J. , Murray R. , O'Keane V. (2002a) The effects of antipsychotic-induced hyperprolactinaemia on the hypothalamic—pituitary—gonadal axisJ Clin Psychopharmacol22: 109—114
41.
Smith S.M. , O'Keane V. , Murray R. (2002b) Sexual dysfunction in patients taking conventional antipsychotic medication . Br J Psychiatry181: 49—55
42.
Spollen J.J. , Wooten R.G. , Cargile C. , Bartztokis G. ( 2004) Prolactin levels and erectile function in patients treated with risperidone . J Clin Psychopharmacol24: 161—166
43.
Strange P.G. (2001) Antipsychotic drugs: importance of dopamine receptors for mechanisms of therapeutic actions and side effects . Pharmacol Rev53: 119—133
44.
Tupala E. , Haapalinna A. , Viitamaa T. , Mannisto P.T. , Saano V. (1999) Effects of repeated low dose administration and withdrawal of haloperidol on sexual behaviour of male rats . Pharmacol Toxicol84: 292—295
45.
Wilson C.A. , (1993) Pharmacological targets for the control of male and female sexual behaviour. In: Riley A J , Peet M , Wilson C (eds) Sexual Pharmacology. Oxford Medical Publications, Oxford , pp. 1—58
46.
Wirshing D.A. , Pierre J.M. , Marder S.R. , Saunders C.S. , Wirshing W.C. (2002) Sexual side effects of novel antipsychotic medications . Schizophr Res56: 25—30
